Features, pricing, ratings, and pros and cons, compared head to head.
Armis Centrix™ for VIPR is a commercial medical device security tool by Armis. SAM rAPId is a commercial ot asset discovery tool by SAM Seamless Network. Compare features, ratings, integrations, and community reviews side by side to find the best medical device security fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output. Startups and mid-market ops teams struggling to inventory IoT and OT devices will find SAM rAPId's fingerprinting database of 500M+ devices far more useful than generic asset scanners that return incomplete or misclassified results. The API-first model means you integrate it directly into your existing workflows instead of running another scanning tool, and batch identification lets you process thousands of devices without manual effort. Skip this if your network is purely IT infrastructure with standard servers and workstations; you'll get better value from cheaper CMDB tools that don't need the fingerprinting layer SAM rAPId is built around.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output.
Startups and mid-market ops teams struggling to inventory IoT and OT devices will find SAM rAPId's fingerprinting database of 500M+ devices far more useful than generic asset scanners that return incomplete or misclassified results. The API-first model means you integrate it directly into your existing workflows instead of running another scanning tool, and batch identification lets you process thousands of devices without manual effort. Skip this if your network is purely IT infrastructure with standard servers and workstations; you'll get better value from cheaper CMDB tools that don't need the fingerprinting layer SAM rAPId is built around.
Healthcare-focused vuln mgmt platform for medical device security & risk prioritization
API for device identification & CVE enrichment using device fingerprinting.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Armis Centrix™ for VIPR vs SAM rAPId for your medical device security needs.
Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..
SAM rAPId: API for device identification & CVE enrichment using device fingerprinting. built by SAM Seamless Network. Core capabilities include Device identification returning manufacturer, class, model, sub-model, product name, and OS, Support for multiple types of network and device data inputs, Individual and batch device identification..
Both serve the Medical Device Security market but differ in approach, feature depth, and target audience.
Armis Centrix™ for VIPR differentiates with Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization. SAM rAPId differentiates with Device identification returning manufacturer, class, model, sub-model, product name, and OS, Support for multiple types of network and device data inputs, Individual and batch device identification.
Armis Centrix™ for VIPR is developed by Armis. SAM rAPId is developed by SAM Seamless Network. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Armis Centrix™ for VIPR and SAM rAPId serve similar Medical Device Security use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox